Global burden, distribution and prevention of β-thalassemias and hemoglobin e disorders

Expert Review of Hematology

Volumn 3, Issue 1, 2010, Pages 103-117

  Colah, Roshan ^a   Gorakshakar, Ajit ^a   Nadkarni, Anita ^a  

^a KEM HOSPITAL   (India)

Author keywords

thalassemia; Control strategy; Distribution of mutations; Global frequency; Hemoglobin E

Indexed keywords

BETA GLOBIN; HEMOGLOBIN E;

BETA GLOBIN GENE; BETA THALASSEMIA; CONTROL STRATEGY; CULTURAL FACTOR; DIAGNOSTIC TEST; EUROPE; GENE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HEMOGLOBIN E DISORDER; HEMOGLOBINOPATHY; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; INCIDENCE; INDIA; INTERNATIONAL COOPERATION; MEDICAL EXAMINATION; MIDDLE EAST; NORTH AFRICA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RELIGION; REVIEW; SCREENING; SOCIAL CLASS; SOUTHEAST ASIA; SOUTHERN EUROPE; UNITED STATES;

BETA-THALASSEMIA; HEMOGLOBIN E; HUMANS; MUTATION;

EID: 77953406829     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.09.74     Document Type: Review

References (120)

1. Weatherall DJ, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited disorders of hemoglobin In: Disease Control Priorities in Developing Countries (2nd Edition). Jamison D, Breman J, Measham A et al. (Eds). Oxford University Press and the World Bank, NY, USA, 663-680 (2006).
2. Weatherall DJ, Clegg JB. The Thalassemia Syndromes (4th Edition). Blackwell Science, Oxford, UK (2001).
3. Report of a Joint WHO-March of Dimes meeting Geneva, Switzerland, 17-19 May 2006. World Health Organization (2006).
4. Flatz G, Sanguansermsri T, Sengchanh S, Horst D, Horst J. The 'hot spot' of HbE [b26 (b8) GluLys] in Southeast Asia: b-globin anomalies in the Lao Theung population of Southern Laos. Hemoglobin 28(3), 197-204 (2004).
5. Fucheroen S, Winchagoon P. Prevention and control of thalassemia in Asia. Asian Biomedicine 1, 1-6 (2007).
6. De M, Halder A, Podder S. Anemia and hemoglobinopathies in tribal populations of eastern and north eastern India. Hematology 11(5), 371-373 (2006).
7. Deka R, Reddy AP, Mukherjee BN et al. Hemoglobin E distribution in ten endogamous population groups of Assam, India. Hum. Hered. 38(5), 261-266 (1988).
8. Chotivanich K, Udomsangpetch R, Pattanpanyasat K et al. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria. Blood 100(4), 1172-1176 (2002).
9. Das MK, Dey B, Roy M, Mukherjee BN. High prevalence of hemoglobin E in three populations of the Malda district, West Bengal, India. Hum. Hered. 41(2), 84-88 (1991).
10. Antonarakis SE, Orkin SH, Kazazian HH Jr et al. Evidence for multiple origins of the E globin gene in South East Asia. Proc. Natl Acad. Sci. USA 79(21), 6608-6611 (1982).
11. Das SK, De M, Bhattacharya DK, Sengupta B, Das N, Talukder G. Interaction of different hemoglobinopathies in eastern India with a view to establish genotype phenotype correlation. Am. J. Hum. Biol. 12 (4), 454-459 (2000).
12. Flatz G, Pik C, Sundharagiati B. Malaria and hemoglobin E in Thailand. Lancet ii, 385-386 (1964).
13. Voge l F, Motulsky AG. Natural selection and population history: HbE and b-thalassemia. In: Human Genetics, Problems and Approaches (3rd Edition). Springer-Verlag, Berlin, Germany 528-532 (1996).
14. Jai Vigyan S & T Mission Project on Community Control of Thalassemia Syndromes - Awareness, Screening, Genetic Counseling & Prevention. A National Multicentric Task Force Study of ICMR- (2000-2005) Mohanty D, Colah R, Gorakshakar A (Eds). Indian Council of Medical Research, New Delhi, India (2008).
15. Management of Hemoglobin disorders. Report of Joint WHO-TIF meeting, Nicosia, Cyprus 16-18, November 2007. World Health Organization, Geneva, Switzerland (2008).
16. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Organ. 86 (6), 480-487(2008).
17. Weatherall DJ, Clegg JB. Inherited hemoglobin disorders: An increasing global health problem. Bull. World Health Organ. 79(8), 704-712 (2001).
18. Cao A, Conqiu R, Sollaino MC et al. Thalassemia and glucose 6 phosphate dehydrogenase screening in 13 to 14 year old students of the Sardinian population: preliminary findings. Community Genet. 11(3), 121-128 (2008).
19. Martins MC, Olim G, Melo J, Magalhaes HA, Rodriques MO. Hereditary anemias in Portugal: epidemiology, public health significance and control. J. Med. Genet. 30(3), 235-239 (1993).
20. Falchetti M, Lupi R, Ottini L. Prevention of Mediterranean anemia in Latium: Ida Bianco archives. Med. Secoli. 18, 241-261 (2006).
21. Bianco I, Graiani B, Leorne M et al. A screening programme for a prospective prevention of Mediterranean anemia in Latium: results of seven years work. J. Med. Genet. 21(4), 268-271 (1984).
22. Samavat A, Modell B. Iranian national thalassemia screening programme BMJ 329(7475), 1134-1137(2004).
23. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N. Engl. J. Med. 347(15), 1162-1168 (2002).
24. Colah R, Thomas M, Mayekar P. Assessing the impact of screening and counseling high school children for thalassemia in India. J. Med. Screen. 14(3), 158 (2007).
25. Colah R, Surve R, Wadia M et al. Carrier screening for b-thalassemia during pregnancy in India: a 7 year evaluation. Genet. Test. 12(2), 181-185 (2008).
26. Galanello R. Screening and diagnosis for hemoglobin disorders. In: Prevention of thalassemia and other hemoglobin disorders. Eleftheriou A, Traeger-Synodinos J, Old J, Petrou M, Angastiniotis M (Eds). Thalassemia International Federation, Nicosia, Cyprus, 34-60 (2003).
27. Fucharoen G, Sanchaisuriya K, Sae-Ung N, Dangwibul S, Fucharoen S. A simplified screening strategy for thalassemia and HbE in rural communities in South-East Asia. Bull. World Health Organ. 82(5), 364-372 (2004).
28. Mamtani M, Das K, Jawahirani A, Raghuwani V, Kulkarni H. Is NESTROFT sufficient for mass screening of b thalassemia trait? J. Med. Screen. 14(4), 169-173 (2007).
29. Singh SP, Gupta SC. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting b thalassemia trait. Singapore Med. J. 49(10), 823-826 (2008).
30. Colah R, Surve R, Sawant P et al. HPLC studies in hemoglobinopathies. Ind. J. Pediatr. 74(7), 657-662 (2007).
31. Garewal G, Das R, Awasthi A et al. The clinical significance of the spectrum of interactions of CAP +1 (A->C), a silent b-globin gene mutation, with other b-thalassemia mutations and globin gene modifiers in North Indians. Eur. J. Haematol. 79(5), 417-421 (2007).
32. Giambona A, Passarello C, Vinciguerra M et al. Significance of borderline HbA2 values in an Italian population with a high prevalance of b-thalassemia. Haematologica 93 (9), 1380-1384 (2008).
33. Angastiniotis M. Epidemiology In: Prevention of Thalassemia and Other Hemoglobin Disorders. Galanello R, Eleftheriou A, Traeger-Synodinos J, Old J, Petrou M, Angastiniotis M (Eds). Thalassemia International Federation, Nicosia, Cyprus., 10-23 (2003).
34. Modell B, Darlison M, Birgens H et al. Epidemiology of hemoglobin disorders in Europe: an overview. Scand. J. Clin. Lab. Invest. 67 (1), 39-69 (2007).
35. Vichinsky E, Macklin EA, Waye JS, Lorry F, Olivieri N. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics 116(6), 818-825 (2005).
36. Samara M, Chiotoglou I, Kalamaras A et al. Large-scale population genetic analysis for hemoglobinopathies reveals different mutation spectra in central Greece compared to the rest of the country. Am. J. Hematol. 82(7), 634-636 (2007).
37. Boussiou M, Karababa P, Sinopoulou K et al. The molecular heterogeneity of b-thalassemia in Greece. Blood Cells Mol. Dis. 40 (3), 317-319 (2008).
38. Sozouz A, Berkalp A, Figus A et al. b thalassemia mutations in Turkish cypriots. J. Med. Genet. 25(11), 766-768 (1988).
39. Baysal E, Indrak K, Bozhurt G et al. The b-thalassemia mutations in the population of Cyprus. Br. J. Haematol. 81(4), 607-609 (1992).
40. Villegas A, Ropero P, Gonzalez FA, Anguita E, Espinos D. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin 25(3), 273-283 (2001).
41. Calvo-Villas JM, de la Iglesia Inigo S, Ropero Gradilla P, Zapata Ramos MF, Cuesta Tovar J, Sicilia Guillen F. Molecular characterization of heterozygous b-thalassemia in Lanzarote, Spain. Med. Clin. (Barc.) 130(12), 450-452 (2008).
42. Tamagnini GP, Goncalves P, Ribeiro MLS et al. b-thalassemia mutations in the Portuguese: high frequencies of two alleles in restricted populations. Hemoglobin 17(1), 31-40 (1993).
43. Cabeda JM, Correia C, Estavinho A et al. Unexpected pattern of b-globin mutations in b-thalassemia patients from northern Portugal. Br. J. Haematol. 105(1), 68-74 (1999).
44. Milland M, Berge-lefrance JL, Lena D et al. Oligonucleotide screening of b-thalassemia mutations in the south east of France. Hemoglobin 11, 317-327 (1987).
45. Rosatelli MC, Tuveri T, Scalas MT et al. Molecular screening and fetal diagnosis of b-thalassemia in the Italian population. Hum. Genet. 89, 585-589 (1992).
46. Rady MS, Baffico M, Khalifa AS et al. Identification of Mediterranean b-thalassemia mutations by reverse dot-blot in Italians and Egyptians. Hemoglobin 21(1), 59-69 (1997)
47. Rosatelli MC, Dozy A, Faa V et al. Molecular characterization of b-thalassemia in the Sardinian population. Am. J. Hum. Genet. 50(2), 422-426 (1992).
48. Di Marzo R, Dowling CE, Wong C, Maggio A , Kazazian HH Jr. The spectrum of the b-thalassemia mutations in Sicily. Br. J. Haematol. 69, 393-397 (1988).
49. Efremov GD. Thalassemias and other hemoglobinopathies in the Republic of Macedonia. Hemoglobin 31(1), 1-15 (2007).
50. Boletini E, Svobodova M, Kutlar A et al. Sickel cell anemia, sickle cell b-thalassemia, and thalassemia major in Albania: characterization of mutations. Hum. Genet. 93, 182-187 (1994).
51. De Angioletti M, Lacerra G, Carestia C. 6th International Conference on Thalassemia and the Haemoglobinopathies. Malta (1997) (Abstract 148).
52. Kulier AM, Rasulor IMR, Dadasheva T et al. Thalassemia in Azerbaijan. J. Med. Genet. 31, 209-212 (1994).
53. Haghi M, Khorshidi S, Hosseinpour Feizi MA et al. b-thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin 33(2), 109-114 (2009).
54. Indrak K, Brabec V, Indrakova J et al. Molecular characterization of b-thalassemia in Czechoslovokia. Hum. Genet. 88, 399-404 (1992).
55. Petkov GH, Efremov GD, Efremov DG et al. b-thalassemia in Bulgaria. Hemoglobin 14(1), 25-33 (1990).
56. Petkov GH, Efremov GD. Molecular basis of b-thalassemia and other hemoglobinopathies in Bulgaria: an update. Hemoglobin 31(2), 225-232 (2007).
57. Al-Obaidli A, Hamodat M, Fawzi Z, Abu-Laban M, Gerard N, Krishnamoorthy R. Molecular basis of thalassemia in Qatar. Hemoglobin 31(2), 121-127 (2007).
58. Jassim N, Merghoub T, Pascaud O et al. Molecular basis of b-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann. NY Acad. Sci. USA 850, 407-409 (1998).
59. Daar S, Hussein HM, Merghoub T, Krishnamoorthy R. Spectrum of b-thalassemia mutations in Oman. Ann. NY Acad. Sci. 850, 404-406 (1998).
60. El Hazmi MAF, Warsy AS, Al-Swailem AR. The frequency of 14 b-thalassemia mutations in the Arab population. Hemoglobin 19, 353-360 (1995).
61. Al-Ali AK, Al-Ateeq S, Imamawerdi BW et al. Molecular basis of b-thalassemia in the eastern province of Saudi Arabia. J. Biomed. Biotechnol. 2005(4), 322-325 (2005).
62. El Kalla S, Mathews AR. Molecular characterization of b-thalassemia in the United Arab Emirates. Hemoglobin 17, 355-362 (1993).
63. Quaife R, Al-Gazali L, Abbes S et al. The spectrum of b-thalassemia mutations in the UAE national population. J. Med. Genet. 31(1), 59-61 (1994).
64. Adekile AD, Gu, LH, Baysal E et al. Molecular characterization of a-thalassemia determinants, b-thalassemia alleles and bS haplotypes among Kuwaiti Arabs. Acta Hematol. 92 (4), 176-181 (1994).
65. Adekile A, Haider M, Kutlar F et al. Mutations associated with b-thalassemia intermedia in Kuwait. Med. Princ. Pract. 14(Suppl. 1), 69-72 (2005).
66. Najmabadi H, Karimi-Nejad R, Sahebjan S. The b-thalassemia mutation spectrum in the Iranian population. Hemoglobin 25(3), 285-296 (2001).
67. Kiani AA, Mortazavi Y, Zeinali S, Shirkhani Y. The molecular analysis of b-thalassemia mutations in Lorestan Province, Iran. Hemoglobin 31(3), 343-349 (2007).
68. Curuk MA, Arpaci A, Attila G et al. Genetic heterogeneity of b-thalassemia at Cukurova in Southern Turkey. Hemoglobin 25(2), 241-245 (2001).
69. Tadmouri GO, Tuzmen S, Ozcelik H et al. Molecular population genetic analyses of b-thalassemia in Turkey. Am. J. Haematol. 57(3), 215-220 (1998).
70. Chehab FF, Derkaloustian V, Khouri FP, Deeb SS, Kan YW. The molecular basis of b-thalassemia in Lebanon. Blood 69, 1141-1145 (1987).
71. Zahed L, Qatanani M, Nabulsi M, Taher A. b-thalassemia mutations and haplotype analysis in Lebanon. Hum. Hered. 47(5), 241-249 (1997).
72. Sadiq MFG, Huisman THJ. Molecular characterization of b-thalassemia in North Jordan. Hemoglobin 18 (4-5), 325-332 (1994).
73. Sadiq NF, Eigel A, Horst J. Spectrum of b-thalassemia in Jordon. Identification of two novel mutations. Am. J. Hematol. 68, 16-22 (2001).
74. Kyriacou K, Al Quobaili F, Pavlou E et al. Molecular characterization of b-thalassemia in Syria. Hemoglobin 24(1), 1-13 (2000).
75. Old J, Khan S, Verma I, Fucharoen S et al. A multicentre study in order to define further the molecular basis of b-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria and India and to develop a simple molecular diagnostic strategy by ARMS- PCR. Hemoglobin 25 (4), 397-407 (2001).
76. Al-Allawi NA, Jubrael JM, Hughson M. Molecular characterization of b thalassemia in the Dohuk region of Iraq. Hemoglobin 30(4), 479-486 (2006).
77. El-Latif MA, Filon D, Rund D, Oppenheim A, Kannan M. The b+ IVS 1-6 (T-C) mutation accounts for half of the thalassemia chromosomes in the Palestine populations of the mountain region. Hemoglobin 26(1), 33-40 (2002).
78. Darwish HM, El-Khatib FF, Ayesh S. Spectrum of b-globin gene mutations among thalassemia patients in the West Bank region of Palestine. Hemoglobin 29(2), 119-132 (2005).
79. Filon D, Oron V, Krichevski S, Shaag A et al. Diversity of b-globin mutations in Israeli ethnic groups reflects recent historic events. Am. J. Hum. Genet. 54, 836-843 (1994).
80. Waye JS, Borys S, Eng B et al. Spectrum of b-thalassemia mutations in Egypt. Hemoglobin 23(3), 255-261 (1999).
81. Hussein G, Fawzy M, Serafi TE et al. Rapid detection of b-thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hemoglobin 31(1), 49-62 (2007).
82. El-Gawhary, El-Shafie S, Niazi M, Aziz M, El-Beshlawy. Study of b-thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian thalassemia patients. Hemoglobin 31(1), 63-69 (2007).
83. Bennani C, Tamouza R, Rouabhi F et al. The spectrum of b-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br. J. Hematol. 84(2), 335-337 (1993).
84. Bouhass R, Perrin P, Trabuchet G. The spectrum of b-thalassemia mutations in the Oran region of Algeria. Hemoglobin 18(3), 211-219 (1994).
85. Agouti I, Badens C, Abouyoub A. Genotypic correlation between six common b-thalassemia mutations and the Xmn I polymorphism in the Moroccan population. Hemoglobin 31(2), 141-149 (2007).
86. Agouti I, Badens C, Abouyoub A, Levy N, Bennani M. Molecular basis of b-thalassemia in Morocco: possible origins of the molecular heterogeneity. Genet. Testing 12(4), 563-568 (2008).
87. Fattoum S, Messaoud T, Bibi A. Molecular basis of b-thalassemia in the population of Tunisia. Hemoglobin 28(3), 177-187 (2004).
88. Chouk I, Daoud BB, Mellouli F et al. Contribution to the description of the b-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin 28(3), 189-195 (2004).
89. Fonseca SF, Kerbauy J, Escrivao C et al. Genetic analysis of b-thalassemia major and b-thalassemia intermedia in Brazil. Hemoglobin 22(3), 197-207 (1998).
90. Araújo AS, Silva WA, Leão SA et al. A different molecular pattern of b-thalassemia mutations in northeast Brazil. Hemoglobin 27(4), 211-217 (2003).
91. Reichert VC, de Castro SM, Wagner SC, de Albuquerque DM, Hutz MH, Leistner- Segal S. Identification of b thalassemia in South Brazilians. Ann. Hematol. 87(5), 381-384 (2008).
92. Varela V, Rossetti LC, Binaghi A, Targovnik HM, Abreu MS. Molecular genetics of the thalassemias in Argentina. Sangre (Barc.) 44(3), 210-215 (1999).
93. Bragós IM, Noguera NI, Morisoli L, Milani AC. Most frequent mutations of b-thalassemia in Rosario, Argentina. Haematologica 85(1), 101-102 (2000).
94. Torres FA, Bonduel M, Sciuccati G et al. b thalassemia major in Argentina. Medicina (B Aries) 62(2), 124-134 (2002)
95. Rossetti L, Targovnik H, Varela V. The molecular basis of b-thalassemia in Argentina. Influence of the pattern of immigration from the Mediterranean Basin. Haematologica 89(6), 746-747 (2004).
96. Muniz A, Martinez G, Lavinha J, Pacheco P. b-thalassemia in Cubans: novel allele increases the genetic diversity at the HBB locus in the Caribbean. Am. J. Hematol. 64(1), 7-14 (2000).
97. Baig SM, Azhar A, Hassan H et al. Spectrum of b-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis. Haematologica 91(1), 13-15 (2006).
98. Hafeez M, Aslam M, Ali A, Rashid Y, Jafri H. Regional and ethnic distribution of b-thalassemia mutations and effect of consanguinity in patients referred for prenatal diagnosis. J. Coll. Physicians Surg. Pak. 17(3), 144-147 (2007).
99. Verma IC, Saxena R, Thomas E, Jain PK. Regional distribution of b-thalassemia mutations in India. Hum. Genet. 100(1), 109-113 (1997).
100. Edison ES, Shaji RV, Devi SG et al. Analysis of b globin mutations in the Indian mutation in the Indian population: presence of rare and novel mutations and region-wise heterogeneity. Clin. Genet. 73(4), 331-337 (2008).
101. Colah R. Gorakshakar A. Nadkarni A et al. Regional heterogeneity of b-thalassemia mutations in the multi ethnic Indian population. Blood Cells Mol. Dis. 42(3), 241-246 (2009).
102. Fisher CA, Premawardhena A, de Silva S et al. The molecular basis for the thalassemias in Sri Lanka. Br. J. Haematol. 121(4), 662-671(2003).
103. Furuumi H, Firdous N, Inoue T et al. Molecular basis of b-thalassemia in the Maldives. Hemoglobin 22(2), 141-151, (1998).
104. George E, Li HJ, Fei YJ et al. Types of thalassemia among patients attending a large university clinic in Kuala Lumpur, Malaysia. Hemoglobin 16(2), 51-66 (1992).
105. Thong MK, Tan JA, Tan K, Yap SF. Characterization of b globin gene mutations in Malaysian children: a strategy for the control of b thalassemia in a developing country. J. Trop. Pediatr. 51 (6), 328-333 (2005)
106. Thein SL, Winichagoon P, Hesketh C. The molecular basis of b-thalassemia in Thailand: application to prenatal diagnosis. Am. J. Hum. Genet. 47(3), 369-375 (1990).
107. Laosombat V, Fucharoen SP, Panich V et al. Molecular basis of b thalassemia in the South of Thailand. Am. J. Hematol. 41(3), 194-198 (1992).
108. Verma IC, Kleanthous M, Saxena R et al. Multicentre study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin 25(4), 397-407 (2001).
109. Xu XM, Zhou YQ, Luo GX et al. The prevalence and spectrum of a and b thalassemia in Guangdong Province: implications for the future health burden and population screening. Clin. Pathol. 57(5), 517-522 (2004).
110. Pan HF, Long GF, Li Q et al. Current status of thalassemia in minority populations in Guangxi, China. Clin. Genet. 71(5), 419-426 (2007).
111. Ng IS, Ong JB, Tan CL, Law HY. b-thalassemia mutations in Singapore - a strategy for prenatal diagnosis. Hum. Genet. 94(4), 385-388 (1994).
112. Lie Injo LE, Cai SP, Wahidijat I et al. b thalassemia mutations in Indonesia and their linkage to b haplotypes. Am. J. Hum. Genet. 45 (6), 971-975 (1989).
113. Chang JG, Lin CP, Liu TC et al. Molecular basis of b-thalassemia minor in Taiwan. Int. J. Hematol. 59 (4), 267-272 (1994).
114. Ko TM, Tseng LH, Hsu PM et al. Molecular characterization of b-thalassemia in Taiwan and the identification of two new mutations. Hemoglobin 21(2), 131-142 (1997).
115. Peng CT, Wu JY, Tsai CH et al. Molecular diagnosis of patients with b-thalassemia major in central Taiwan by amplified created restriction site analysis. J Hum. Genet. 43(4), 237-241 (1998).
116. Brown JM, Thein SL, Mar KM, Weatherall DJ. The spectrum of b thalassemia in Burma. Br. J. Hematol. 81(4) 574-578 (1992).
117. Win N, Harano T, Harano K et al. A wider molecular spectrum of b-thalassemia in Myanmar. Br. J Haematol. 117(4), 988-992 (2002).
118. Ko TM, Caviles AP Jr, Hwa HL, Liu CW, Hsu PM, Chung YP. Prevalence and molecular characterization of b-thalassemia in Filipinos. Ann. Hematol. 77(6), 257-260 (1998).
119. Park SS, Cho HI; b-thalassemia in the Korean population. Int. J. Hematol. 76(Suppl. 2), 93-95 (2002).
120. Park SS, Lee YJ, Kim JY, Joo SI, Hattori Y, Ohba Y, Cho HI. b-thalassemia in the Korean population. Hemoglobin 26(2), 135-145 (2002).